Scholarship Created in Memory of Long-Time 340B Leader Carl Taylor

The Carl Taylor Pharmacy Administration Scholarship at the University of North Carolina (UNC) Eshelman School of Pharmacy was announced this morning at the 340B Coalition Winter Conference in San Diego. Taylor, 76, the longtime pharmacy director at Piedmont Health Services in Chapel Hill, N.C., died last Sept. 24.

An endowed scholarship at the University of North Carolina (UNC) Eshelman School of Pharmacy has been established in memory of Carl Taylor, the longtime pharmacy director at Piedmont Health Services in Chapel Hill, N.C. Taylor, age 76, died last Sept.

Read More »

Vertex Providing Refunds for 340B Overcharges on Cystic Fibrosis Drug Trikafta

Vertex Pharmaceuticals is giving 340B covered entities refunds for overcharges from Q2 2021 through Q4 2021 on its cystic fibrosis combination medicine Trikafta.

Biopharmaceutical company Vertex is providing refunds to 340B covered entities for overcharges on its cystic fibrosis (CF) combination medicine Trikafta for the period from Q2 2021 through Q4 2021, according to a public notice on the U.S. Health Resources and

Read More »

340B Report Publisher and CEO Forecasts What to Expect After November Congressional Elections

AHA and RWC-340B again took aim at the 340B ACCESS Act introduced this spring.

340B Report Publisher and Chief Executive Officer Ted Slafsky says in his latest column for Omnicell’s blog that “all signs foretell a Republican takeover of the House and a very good possibility of the GOP assuming control of the closely

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live